CJC-1295 DAC

From WikiAlpha
Jump to: navigation, search
CJC-1295 DAC
Area served Manufacturer
Website Polypeptide.ltd
CJC-1295 DAC

CJC-1295 DAC

List of Suppliers

Polypeptide [1]

CJC-1295 is a synthetic analog of growth hormone-releasing hormone (GHRH) designed to elevate plasma levels of growth hormone and insulin-like growth factor 1 (IGF-1). The addition of DAC (Drug Affinity Complex) to CJC-1295 extends its plasma half-life.

Product Details of [ CJC-1295 DAC ]

  • Name:CJC-1295 DAC
  • Sequence: Tyr-D-Ala-Asp-Ala-le-Phe- Th-GIn-Ser-Ty-Arg-Lys-Val-Leu-Ala-GIn-Leu-Se-Ala-Arg-Lys-Leu-Leu-GIn-Asp-lle-Leu-Ser-Arg
  • Molecular Formula: C152H252N44O42
  • Molecular Weight: 3367.954 g/mol
  • PubChem CID: 56841945

CJC-1295 DAC Peptide Research

CJC-1295 is a derivative of the initial 29 amino acids of growth hormone-releasing hormone (GHRH), making it structurally akin to other GHRH analogs such as Sermorelin. [2] Growth hormone-releasing hormone (GHRH) has undergone several modifications to create analogs that retain certain effects while eliminating others. Among these modifications is CJC-1295, which encompasses the first 29 amino acids of GHRH. CJC-1295, technically a maleimido derivative of hGRF(1-29), was developed to enhance solubility as a growth hormone secretagogue and facilitate large-scale production while maintaining the physiological actions of GHRH.

Storage

Sealed in dry,Room Temperature

Manufacturer

Production capacity: Provide customization


References